Dilated Left Atrium Research Articles

Utilidad del Holter insertable con detección remota en el diagnóstico etiológico del ictus criptogénico: análisis de 73 pacientes

IntroductionCryptogenic stroke constitutes 25% of all ischemic strokes, of which 20–30% are due to atrial fibrillation (AF). With the aim of increasing the detection rate, implantable long-term monitoring devices have emerged. The study of the profile of the ideal candidate subsidiary to such monitoring would provide a better understanding of the mechanisms underlying this subtype of stroke. ObjectiveTo determine which variables are related and can predict the detection of silent AF in patients with cryptogenic stroke. Patients and methodsThis is a longitudinal cohort with recruitment from March 2017 to May 2022. They are patients with an implantable monitoring device and cryptogenic stroke with a minimum monitoring of one year. ResultsThe total number of patients included was 73, with a mean age of 58.8 years, 56.2% were male. AF was detected in 21 patients (28.8%). The most frequent cardiovascular risk factors were hypertension (47.9%) and dyslipidemia (45.2%). The most frequent topography was cortical (52%). Regarding the echocardiographic parameters, 22% had a dilated left atrium, 19% had a patent foramen ovale, and 22% had high-density supraventricular tachycardia (>1%) on Holter monitoring. In the multivariate analysis, the only variable that predicts AF is the presence of high-density supraventricular tachycardia, with an area under the curve of 0.726 (CI 0.57–0.87, p=0.04), sensitivity of 47.6%, specificity of 97.5%, positive predictive value of 90.9%, negative predictive value of 78.8%, and accuracy of 80.9%. ConclusionsThe presence of high-density supraventricular tachycardia can be indicative for predicting silent AF. No other variables have been observed that allow us to predict detection of AF in these patients.

Pulmonary vein isolation in patients with atrial fibrillation and severely dilated left atrium – is it worth it?

Pulmonary vein isolation in patients with atrial fibrillation and severely dilated left atrium – is it worth it?

Left Atrial Remodeling in Patients With Severe Rheumatic Mitral Stenosis and Sinus Rhythm Using Two-Dimensional and Three-Dimensional Speckle Tracking Echocardiography

In mitral stenosis (MS), the combination of an increase in left atrium (LA) pressure and atrial inflammatory response is accompanied by increase in interstitial fibrosis of the atrial wall with disorganization of atrial muscle bundles, LA dysfunction and subsequently LA dilatation. We aimed to assess the effect of severe rheumatic MS on LA volumes and mechanics. We enrolled 40 patients with pure severe rheumatic MS and sinus rhythm as a patient group and 30 healthy subjects as a control group. All patient and control groups underwent two-dimensional (2D) transthoracic echo to measure left ventricle (LV) dimensions, function, LA deformations, estimated systolic pulmonary artery pressure (EPAP), and left ventricle global longitudinal strain (LV GLS). Also LA volumes and mechanics (LA strain during LV systole (reservoir function) and LV diastole (early = conduit, and late = booster pump = atrial contraction)) were measured by three-dimensional (3D) transthoracic echo; mitral valve (MV) area was measured by 3D transesophageal echo (as routine pre-percutaneous MV commissurotomy using multiplanar reconstruction in mid-esophageal apical long-axis view from LA prospective). By 2D transthoracic echo, patient group revealed significantly lower all LA function vs. control group including LA strain during reservoir (24 ± 6 vs. 43 ± 3, P < 0.001), LA strain during conduit (-11 ± 3 vs. -25 ± 2, P < 0.001), and during booster pump (-13 ± 4 vs. -18 ± 1, P < 0.001). EPAP was significantly higher in patient group (48 ± 7 vs. 27 ± 4 in control group). LV GLS was significantly lower in patient group (-16±2% vs. -23±2% in control group). All 3D LA volumes were significantly higher in patient group than control group including maximum LA volume (LAVmax) (76 ± 18 vs. 50 ± 5, P < 0.001), indexed LA volume (LAVi) (44.6 ± 10.1 vs. 28.7 ± 3.7, P < 0.001), LV minimum volume (LAVmin) (51 ± 15 vs. 30 ± 4, P < 0.001), and LA volume pre atrial contraction (LAVpre A) (63 ± 15 vs. 41 ± 6, P < 0.001). Also, there was significantly decreased LA strain using 3D speckle tracking echo in patient group including systolic deformation of LA (reservoir function) (23 ± 6 vs. 41 ± 3, P < 0.001) and diastolic deformation, early diastole (conduit function) (-10 ± 2 vs. -24 ± 2, P < 0.001), and late diastole (booster pump function) (-13 ± 4 vs. -18 ± 1, P < 0.001). All LA function markedly reduced in pure severe rheumatic MS. The reduction of LA mechanics is directly related to the degree of reduction of the stenotic MV area. LV GLS significantly reduced in severe MS and its reduction is directly related to the degree of reduction of the stenotic MV area and the LAVi by 3D echo.

Surgical Management of Giant Left Atrium during Mitral Valve Surgery

Rheumatic mitral valve disease, a preventable and eradicable condition, remains the primary indication of mitral valve surgery in developing countries. Delayed surgery is the main cause of giant left atrium (LA). This extreme dilatation of LA causes various complications compromising hemodynamic stability. We describe herein a patient with severe mitral stenosis and giant LA who had successful surgical correction by mitral valve replacement with reduction of the size of a LA.

Preliminary findings on left atrial appendage occlusion simulations applying different endocardial devices.

Atrial fibrillation (AF) is one of the most investigated arrhythmias since it is associated with a five-fold increase in the risk of strokes. Left atrium dilation and unbalanced and irregular contraction caused by AF favour blood stasis and, consequently, stroke risk. The left atrial appendage (LAA) is the site of the highest clots formation, increasing the incidence of stroke in AF population. For many years oral anticoagulation therapy has been the most used AF treatment option available to decrease stroke risk. Unfortunately, several contraindications including bleeding risk increase, interference with other drugs and with multiorgan functioning, might outweigh its remarkable benefits on thromboembolic events. For these reasons, in recent years, other approaches have been designed, including LAA percutaneous closure. Unfortunately, nowadays, LAA occlusion (LAAO) is restricted to small subgroups of patients and require a certain level of expertise and training to successfully complete the procedure without complications. The most critical clinical problems associated with LAAO are represented by peri-device leaks and device related thrombus (DRT). The anatomical variability of the LAA plays a key role in the choice of the correct LAA occlusion device and in its correct positioning with respect to the LAA ostium during the implant. In this scenario, computational fluid dynamics (CFD) simulations could have a crucial role in improving LAAO intervention. The aim of this study was to simulate the fluid dynamics effects of LAAO in AF patients to predict hemodynamic changes due to the occlusion. LAAO was simulated by applying two different types of closure devices based on the plug and the pacifier principles on 3D LA anatomical models derived from real clinical data in five AF patients. CFD simulations were performed on the left atrium model before and after the LAAO intervention with each device. Blood velocity, particle washout and endothelial damage were computed to quantify flow pattern changes after the occlusion in relation to the thrombogenic risk. Our preliminary results confirmed an improved blood washout after the simulated implants and the capability of foreseeing thrombogenic risk based on endothelial damage and maximum blood velocities in different scenarios. This tool may help to identify effective device configurations in limiting stroke risk for patient-specific LA morphologies.

Late recurrence of atrial fibrillation and flutter in patients referred for elective electrical cardioversion.

Aim The primary aim was to ascertain long-term rates of atrial fibrillation (AF) recurrence in this all-comer patient population undergoing elective electrical cardioversion (DCR). Secondary aims included procedural DCR success, clinical predictors of long-term maintenance of sinus rhythm (SR) and AF related hospitalizations.Material and Methods A retrospective cohort study was conducted. Consecutive patients (n=316) undergoing elective DCR were included.Results Successful immediate reversion to SR was attained in 266 (84 %) of patients. 224 (84 %) patients were followed up for a median period of 3.5 years (IQR 2.7-4.3). Most patients (150 [67 %]) had recurrence of AF / flutter at a median time of 240 days. Clinical predictors of AF recurrence included a history of AF (HR 0.63, p=0.038) and a dilated left atrium (HR 4.13, p=0.048). Maintenance of SR was associated with fewer unplanned hospitalizations for AF (HR 3.25, p&lt;0.01).Conclusion There was high procedural success post DCR. However, long-term rates of AF recurrence were high, and AF recurrences were associated with increased hospitalizations. These findings underscore the importance of clinical vigilance and multi-modal management as part of a comprehensive and effective rhythm control strategy.

Comparison of Hemodynamic Response between Patients with Systolic Heart Failure Differing in Serum Aldosterone Concentrations during and after a 6-Minute Walk Test.

Aldosterone regulates hemodynamics, including blood pressure (BP), and is involved in the development and progression of cardiovascular diseases, including systolic heart failure (HF). While exercise intolerance is typical for HF, neither BP nor heart rate (HR) have specific characteristics in HF patients. This study compares BP and HR profiles during and after standardized exercise between patients with systolic HF with either lower or higher aldosterone concentrations. We measured BP and HR in 306 ambulatory adults with systolic HF (left ventricular ejection fraction (LVEF) <50%) during and after a 6 min walk test (6MWT). All patients underwent a resting transthoracic echocardiography, and venous blood samples were collected for biochemical analyses. The patients were also divided into tertiles of serum aldosterone concentration: T1 (<106 pg/mL), T2 (106 and 263 pg/mL) and T3 (>263 pg/mL), respectively. Individuals from T1 and T2 were combined into T1-T2 as the reference group for comparisons with patients from T3. The individuals from T3 had significantly lower systolic, mean and diastolic BPs at rest, at the end and at 1 and 3 min post-6MWT recovery, as well as a more dilated left atrium and right ventricle alongside a higher concentration of N-terminal pro-B-type natriuretic peptide (NT-proBNP). Higher serum aldosterone concentration in HF patients with an LVEF < 50% is associated with a lower 6MWT BP but not an HR profile.

Prevalence of cardiovascular disease in Sickle cell disease (SCD)- An echocardiographic and pharmacological analysis

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Sickle cell disease (SCD) is an inherited disorder of globin chains that cause haemolysis and chronic organ damage. It is an autosomal recessive condition. SCD is a condition more prevalent in sub-saharan Africa. It is estimated that there are between 12,500 and 15,000 people with SCD in the United Kingdom (UK) in 2014. The prevalence of the disease is increasing due to immigration into the UK and new births. As a result, there is a need to understand cardiovascular complications within this population, as despite a significant increase in longevity for SCD patients over the last few decades, there are significant cardiac complications. Method We present retrospective data from a single center tertiary centre for SCD. A total of 318 patients were followed up from diagnosis to current day with a mean age of 43.4 and median of 42. 136 (43%) were male and 182 (57%) Female. Results A total of 157 (49%) patients underwent a transthoracic echocardiogram (TTE). 56 (17.5%) had a dilated Left Atrium, 36 (11.3%) had Valvular heart disease, 18 (5.7%) Pulmonary Hypertension (PHT) or Right Heart Dysfunction and 17 (5.34%) had a dilated Left Ventricular cavity. 14 patients had Tricuspid regurgitation (13 mild and 1 severe), 15 had Mitral regurgitation (14 mild and 1 moderate), 7 had mild Aortic regurgitation, 6 had Mild Pulmonary regurgitation, 3 had mild Pulmonary Stenosis and 3 were noted to have sclerotic aortic valve. From a Left ventricular systolic function perspective, 151 patients had a normal ejection fraction, 4 had mild Left ventricular systolic dysfunction (LVSD), 1 moderate LVSD and 1 severe LVSD. A normal ejection fraction was defined as &amp;gt;55%, mild 45-55%, moderate 35-45% and severe &amp;lt;35%. 40 (12.60%) Patients were taking Calcium channel blockers (Dihydropyridine), 25 (7.86%) were taking Angiotensin converting enzyme inhibitor/ Angiotensin receptor blocker, 20 (6.29%) taking an anticoagulant (DOAC), 16 (5.03%) were taking a statin, 15(4.72%) taking B blockers, 11(3.46%) taking an antiplatelet, 5(1.57%) patients were taking a loop diuretic, 4 (1.26%) thiazide diuretic, 4 (1.26%) on an alpha blocker and 1(0.3%) patient on digoxin. The prevalence of Atrial Fibrillation was 1.57% (5 patients). Conclusions The Echocardiographic data suggests the commonest findings are of a dilated left atrium, dilated ventricle, valvular heart disease and PHT. The dilated left atrium is secondary to the hyperdynamic states found in sickle cell disease. Despite this being very common the rates of arrhythmia are low. The prevalence of LVSD remains low. The findings of PHT are of particular interest as it guides SCD management with exchange transfusion. The pharmacological data suggests high burden of cardiovascular risk factors i.e. hypertension and hypercholesterolemia despite the young demographic. It is vital to follow up these patients with aggressive primary prevention medications to reduce risk of future cardiovascular events.

Enhanced neutrophil extracellular traps formation in AF patients with dilated left atrium.

Atrial fibrillation (AF) is associated with cardiac remodelling and prothrombotic state. Enhanced neutrophil extracellular traps (NETs) formation has been reported in AF, contributing to thromboembolism. We investigated whether increased left atrium (LA) diameter and reduced left ventricular ejection fraction (LVEF) affect NETs formation and prothrombotic state in AF patients. In 243 AF patients (median CHA2 DS2 -VASc=4) we measured LA diameter and LVEF, 123 of them with LVEF<50%. Moreover, we determined 3 markers of NETosis: circulating citrullinated histone H3 (H3cit), myeloperoxidase (MPO) and peptidylarginine deiminase 4 (PAD4), along with prothrombotic markers, including endogenous thrombin potential, plasma fibrin clot permeability (Ks ) and clot lysis time (CLT). Ischaemic cerebrovascular events, major bleeding and death were recorded during a median follow-up of 53 months, on anticoagulation. LA diameter correlated positively with H3cit, MPO and PAD4, while LVEF was inversely associated with the same NETosis markers. After adjustment for age and body mass index, concentrations of MPO (per 10units; β=-1.9, 95%CI -3.40;-0.42) and H3cit (per 10units; β=2.02, 95%CI 0.61-3.42) were independently associated with LVEF and LA diameter. LA diameter, but not LVEF, correlated inversely with Ks and positively with CLT. The Cox regression analysis revealed that H3cit >6.16 ng/mL (HR=21.76, 95%CI 2.85-166.28, p=.003) and LA diameter > 46 mm (HR=2.89, 95%CI 1.04-8.03, p=.043) independently predicted cerebrovascular ischaemic events (1.9%/year). This hypothesis-generating study suggests that in AF enlarged LA diameter and reduced LVEF are associated with enhanced NETs formation, which might have clinical importance and contribute to thromboembolic events despite anticoagulation.

Anomalous origin of the left main coronary artery from the right pulmonary artery: a case report

Anomalous origin of the left coronary from the right pulmonary artery (AOLCARPA) is an extremely rare anomaly, which has been reported in only a few patients worldwide [1] An 8-month-old male patient weighing 5.7 kg came to our hospital with chief complaints of tachypnea while feeding and failure to thrive. ECG of the patient showed sinus tachycardia. The patient had a heart rate of 140/min and saturation of 99% on room air. Chest radiograph showed cardiomegaly. Transthoracic echocardiography showed moderate mitral regurgitation, dilated left atrium and ventricle, severe left ventricular (LV) dysfunction, global LV hypokinesia with an LV ejection fraction of 15–20%. Flow pattern in the left anterior descending artery and the left circumflex artery was reversed and the right coronary artery (RCA) was dilated. The left main coronary artery (LMCA) origin was not clear. As the diagnosis was unclear, computed tomography coronary angiography (CTCA) was done to delineate the coronary anatomy, which showed an anomalous origin of LMCA from the right pulmonary artery (RPA) (Figs. 1 and 2Figs 1, 2). Blood investigations including complete blood count, and liver and kidney function tests were normal. Preoperative medication of the patient included digoxin, spironolactone, furosemide, and milrinone infusion. The patient was posted for corrective repair of anomalous origin of the left coronary artery from the RPA.Figure 1: Computed tomography coronary angiography showing left main coronary artery (LMCA) arising from the right pulmonary artery (RPA). PROX LAD, proximal left anterior descending artery.Figure 2: (a) Midesophageal (ME) ascending aortic short-axis (SAX) view showing retrograde flow from left main coronary artery (LMCA) to right pulmonary artery (RPA). (b) Midesophageal (ME) four-chamber view showing dilated left ventricle (LV) and mitral regurgitation jet. (c) Origin of LMCA from RPA. LPA, left pulmonary artery; Asc Aorta, ascending aorta.On the day of surgery, the patient was taken to the operating room. Preoperative inotropic support of intravenous infusion of milrinone 0.5 µg/kg/min was continued. After attaching a multiparameter monitor with a five-lead ECG, noninvasive blood pressure monitor, and a pulse oximeter, general anesthesia was induced with intravenous fentanyl 2 µg/kg, midazolam 0.1 mg/kg, vecuronium 0.1 mg/kg, and endotracheal intubation was done. Femoral artery was cannulated for invasive arterial blood pressure monitoring, and central venous catheter was inserted in the right internal jugular vein. Anesthesia was maintained with isoflurane and intermittent boluses of fentanyl and vecuronium. Intraoperative ventilation was instituted with the goals of avoiding hypocarbia, hyperoxia, and alkalosis. An FiO2 of 0.35 was kept with PaO2 targets of 80–100 mm Hg to maintain pulmonary vascular resistance End-tidal carbon dioxide (EtCO2) was maintained between 40 and 42 mm Hg. Pre-bypass transesophageal echocardiography (TOE) examination was carried out with a pediatric 9T probe (Vivid I, GE; Vingmed Ultrasound, Horten, Norway). ME ascending aorta short-axis view showed the origin of LMCA from RPA (Fig. 2a). Midesophageal four-chamber view showed dilated LV and moderate mitral regurgitation (Fig. 2b). Heparin 400 IU/kg was given, and cardiopulmonary bypass was instituted. Cardiopulmonary bypass was established using aortobicaval cannulation with looping of both pulmonary artery branches. Myocardial preservation was obtained with antegrade cold blood potassium cardioplegia into the aorta and main pulmonary artery. Under low pump flows, LMCA origin was identified originating from the RPA (Fig. 2c). Medial trap door was made in the aorta and LMCA was anastomosed to the aorta (coronary translocation). Posterior annuloplasty of the mitral valve was performed through the trans-septal approach. Weaning from the cardiopulmonary bypass was uneventful with minimal inotropic support (milrinone 0.5 µg/kg/min; Epinephrine 0.04 µg/kg/min). The chest was kept open with a sterile membrane cover electively and the patient was shifted to the pediatric ICU with stable hemodynamics. AOLCARPA is an extremely rare congenital coronary anomaly. Only 10–20% of neonates survive till adulthood, and it depends on the adequacy of LV perfusion through collaterals to LCA from RCA and the proportion of coronary steal from the LCA to pulmonary artery [2] Coronary angiogram is usually done to delineate the anatomy and for the diagnosis. In this case, the origin of LMCA could not be visualized on transthoracic echocardiography (TTE) leading to inconclusive diagnosis. CTCA delineated the exact anatomy and showed its origin from RPA. Intraoperative TOE examination also revealed it as a case of AOLCARPA. Anesthetic management of patients presenting with ALOCARPA includes rapid and smooth intubation, while avoiding swings in blood pressure and heart rate. A decrease in pulmonary vascular resistance is avoided by preventing hyperventilation, hyperoxia and hypocarbia [3] The aim is to maintain a PaO2 of 80–100 mm Hg and an EtCO2 of 40–45 mm Hg. Both reduction and increase in afterload can hamper RCA perfusion and stroke volume, respectively. An optimum preload is required to ensure adequate cardiac output. CTCA and TOE examinations are useful modalities for delineating the coronary anatomy and help in planning the perioperative surgical and anesthetic management of the patient.

PERIOPERATIVE MANAGEMENT OF A CASE OF CHRONIC RHEUMATIC HEART DISEASE POSTED FOR EMERGENCY CAESAREAN SECTION

Rheumatic heart disease(RHD) still remains an endemic in India. It is one of the major causes of mortality and morbidity in parturients in developing countries. We present a 26 year old second gravida with history of chronic rheumatic heart disease with multiple valvular disease. She presented with complaints of palpitations, dyspnoea progressing from New York Heart Association (NYHA) class II to class III. On physical examination, patient was pale, had bilateral pedal edema, tachycardia, dyspnoea, undifferentiated murmur on auscultation. Further evaluation revealed anemia, dilated left atrium, moderate mitral regurgitation, mild mitral stenosis, mild aortic regurgitation and fetal distress. Patient was taken for emergency caesarean section in the view of maternal condition and fetal distress. She developed pulmonary edema during surgery and was kept on ventilator to optimize the patient condition with further management. She was successfully extubated after 3 days of meticulous care in intensive care unit (ICU).

28 CONSTRICTIVE PERICARDITIS: A ROOM FOR MULTI-MODALITY IMAGING

Abstract Introduction The diagnosis of constrictive pericarditis can be challenging through conventional imaging. Novel imaging techniques have been proposed to improve it. Clinical Case A 74-year-old man with a previous diagnosis of heart failure with preserved ejection fraction and permanent atrial fibrillation (AF) was admitted because of worsening dyspnea, peripheral edema, and ascites refractory to diuretics therapy. ECG revealed low QRS voltages and AF with normal heart rate and laboratory exams detected increased values of BNP and hepatic stasis indices; blood count and CRP were normal. Echocardiography revealed mildly reduced bi-ventricular pump function (left ventricular ejection fraction = 52%, right ventricular fractional area change = 25%) and slightly increased wall thickness. Atria were moderately dilated (left and right atrium 46 and 44 ml/mq, respectively) and mitral and tricuspid annuli were dilated too. There was inferior vena cava plethora, moderate atriogenic tricuspid regurgitation and mild-to-moderate atriogenic mitral regurgitation. A paradoxical interventricular septal motion and significant respiratory changes on trans-mitral (&amp;gt;25%) and trans-tricuspid (&amp;gt;30%) pulsed Doppler were noted; however, there was no "annulus reversus" (lateral and septal e’ 13 and 11 cm/sec, respectively) at TDI analysis. In contrast, 2D-speckle-tracking global longitudinal strain showed impaired deformation ​​of the lateral segments with relative sparing of the septal segments. The latter pattern has been recently described as "strain reversus" or "hot septum sign". The findings were suspected of constrictive pericarditis, but a chest Computed Tomography excluded pericardial calcifications. Cardiac magnetic resonance (CMR) was then performed revealing a "septal shift" at cine-real time sequences analysis. The pericardium was slightly thickened (4-5 mm) with widespread late gadolinium enhancement but without signs of acute inflammation at T2-weighted imaging. Tricuspid regurgitation was confirmed to be "moderate" after phase-contrast imaging. Cardiac catheterization finally revealed normal coronary arteries and confirmed the diagnosis of constrictive pericarditis (square root sign, equalization of bi-ventricular end-diastolic pressures). The patient underwent pericardiectomy and tricuspid and mitral valve repair and was asymptomatic at 6-months follow-up. Conclusions Constrictive pericarditis represents a potentially reversible cause of heart failure but can be easily missed through conventional imaging. In the present case, advanced echocardiography and CMR were essential to come up with an accurate diagnosis, guiding the patient's clinical management with excellent outcome.

Anesthetic considerations in pediatric renal autotransplantation

BackgroundRenal autotransplantation is a complex procedure involving reimplantation of the renal artery and vein at a different site. Anesthetic management of renal autotransplant is challenging because of associated morbidities and intraoperative hemodynamic changes.Case presentationWe present a case of a 14-month-old male who had severe hypertension and cardiomyopathy due to renal artery stenosis. Echocardiography reported dilated left atrium and left ventricle, moderate to severe left ventricular systolic dysfunction, and a left ventricular ejection fraction of 30%. The renal artery and renal vein were anastamosed to the great vessels. Anesthetic management included maintaining normal baseline diastolic pressure, systemic vascular resistance, and preload and avoiding tachycardia. Milrinone infusion was used.ConclusionsAnesthetic management was challenging as adequate perfusion pressures had to be maintained while keeping the patient hemodynamically stable.

The relationship between serum miR-21 levels and left atrium dilation in elderly patients with essential hypertension.

MicroRNA-21 (miR-21) is related to hypertension and cardiac remodelling. Left atrium (LA) dilation is highly sensitive to small haemodynamic changes in the left ventricle (LV) that are induced by hypertension. This study aimed to elucidate the relationship between miR-21 expression and LA dilation in elderly patients with essential hypertension (EH). In this cross-sectional study, one hundred elderly patients with EH were recruited for the study. According to their left atrium diameters (LADs), the patients were divided into the LA dilation group [42 patients (42%)] and the no-LA dilation group [58 patients (58%)]. The serum levels of miR-21 and chemical biomarkers used in the clinic, such as creatinine, blood urea nitrogen, uric acid, fasting blood glucose, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein cholesterol, Lp(a), apolipoprotein A1 (apoA1), and apolipoprotein B, were measured. All the patients underwent echocardiographic examination, and the LAD, interventricular septum (IVS), right atrium diameter (RAD), right ventricle diameter (RVD), left ventricular end-systolic diameter (LVESD), left ventricular end-systolic diameter (LVEDD) and left ventricular ejection fraction (LVEF) were measured. The levels of miR-21 [8.02 (5.21, 14.39) vs. 6.05 (3.81, 8.95), P = 0.011] and LVEF (67.02 ± 3.82 vs. 64.14 ± 4.43, P = 0.001) were higher in the LA dilation group. The levels of creatinine [70.40 (64.45, 80.15) vs. 63.9(60.1, 73.43)], P = 0.020] were higher in the no-LA dilation group. The levels of HDLC (r = - 0.209, P = 0.037), apoA1 (r = -0.269, P = 0.007) and RAD (r = 0.203, P = 0.043) were significantly correlated with miR-21 expression. The LAD was significantly correlated with the RAD (r = 0.287, P = 0.004), RVD (r = 0.450, P < 0.001), LVEDD (r = 0.248, P = 0.013) and LVEF (r = 0.232, P = 0.020). Multivariate logistic regression revealed that miR-21 significantly influenced LA dilation in elderly patients with EH (P < 0.05). Circulating serum levels of miR-21 are increased in elderly patients with EH with LA dilation. miR-21 levels are significantly correlated with LA dilation in elderly patients with EH, and miR-21 may be a factor related to the clinical pathophysiological occurrence of and treatment for the progression of hypertension-related early heart damage in EH patients.

Pre-operative N-Acetyl Cysteine for Prevention of Atrial Fibrillation After CABG Surgery in Pakistan

Objective: To determine the effect of NAC in prevention of post-operative atrial fibrillation in patients undergoing CABG.&#x0D; Study Design: Quasi experimental study.&#x0D; Place and Duration of Study: Adult Cardiac Intensive Care Unit, Armed Forces Institute of Cardiology &amp; National Institute of Heart Diseases (AFIC&amp;NIHD) Rawalpindi during 6 months.&#x0D; Methodology: 146 patients of both gender undergoing elective CABG were included in the study, having age between 30-70 years. However, any patient with history of arrhythmia including AF, thyroid dysfunction, ejection fraction less than 25%, any valvular lesion, dilated left atrium, dilated left ventricle, dilated right atrium, dilated right ventricle or having right atrial tear during surgery were excluded from the study. By using non-probability consecutive sampling, patients were divided into two groups by using envelope method. One group was given standard treatment (control group) while other group was named as NAC group (experimental group). Data analysis was performed using SPSS version-23. Descriptive statistics were reported as Mean±SD. Categorical variables were reported as frequency and percentage. Chi square test and T-test was used to determine association between different variables.&#x0D; Results: A total of 146 patients with mean age 55.27±7.3 yrs. 127(87%) were male and 19(13%) were females. 28(19.2%) patients had atrial fibrillation while 11(7.5%) patients had ventricular premature contractions (VPC). There was no statistically significant difference between ages (p=0.784), gender (p=0.461), AF (p=0.207) and VPC (p=0.347). Out of 73 (50%) patients from each group; the mean age of NAC group was 55.41±7.3 yrs and of control group was 55.08±7.1 yrs (p=0.784). Gender wise distribution of NAC group had 8(11%) females and 65(89%) males while in control group 11(15%) females and 62(85%) were males. AF was found to be 11(15%) and 17(23.3%) in NAC and control group respectively. In NAC group, VPC was 4 (5.5%) and in control group it was 66 (90.4%).&#x0D; Conclusion: This study shows that NAC decreases the frequency of post-operative atrial fibrillation and ventricular premature contractions, but the decrease is statistically insignificant in Pakistani population. However, keeping in view other beneficial effects of NAC, we would recommend more studies on this subject in Pakistani population.

Abstract 10897: Severe Atrial Dysfunction and Sick Sinus Syndrome in a Patient With Scn5a Mutation

Introduction: SCN5A mutations are associated with numerous cardiovascular conditions, including dilated cardiomyopathy, atrial fibrillation, and sick sinus syndrome. Specific variants in patients with severe atrial dysfunction may be associated with increased risk of stroke even in young patients. Case: This case describes a previously healthy 38-year-old male of French descent who presented with intermittent palpitations and presyncope associated with atrial flutter followed by prolonged conversion pauses up to 7.5 seconds, then followed by junctional bradycardia. Echocardiogram showed a mildly dilated left atrium. Electrophysiology study demonstrated extensive scarring in the left atrium with normal sinus node function and right atrial voltage. No atrial fibrillation was noted. He was also found to have typical atrial flutter and mitral flutter. He underwent cavotricuspid isthmus ablation and mitral annular flutter ablation. Due to his vagal-mediated pauses and junctional rhythm, he also underwent cardioneuroablation aimed at partial denervation. Following this, he had further episodes of junctional rhythm on the days after exercise. He underwent further total cardioneuroablation and was found to have progressive scarring at the sinus node area and sinus node dysfunction, so a permanent pacemaker was placed. He underwent genetic testing which demonstrated SCN5A heterozygous missense pathogenic variant c.2823G&gt;A. Conclusion: The SCN5a gene encodes the alpha subunit of the cardiac sodium channel, which is responsible for initiation and propagation of action potentials. SCN5A variants are associated with a number of cardiovascular conditions. There are reports of stroke in young French patients with severe atrial dysfunction and SCN5A mutations, including variant c.2823G&gt;A, demonstrating that severe atrial dysfunction is a risk factor for stroke regardless of CHADS2VASc score, and specific SCN5A mutations may be associated with increased risk of stroke. Given these reports and absence of relevant guidelines, apixaban was continued indefinitely for prevention of stroke. At follow-up two months later, the patient resumed physical activity and reported symptomatic improvement, without any episodes of syncope or near syncope.

Additional Prognostic Value of Tissue Doppler Evaluation in Patients with Aortic Stenosis and Left-Ventricular Systolic Dysfunction Undergoing Aortic Valve Replacement.

Background and Objectives: Patients with surgical aortic stenosis (AS) show impaired diastolic filling, which is a risk factor for early and late mortality after aortic valve replacement (AVR). There is a paucity of information concerning the impact of restrictive diastolic filling and the evolution of diastolic dysfunction in the early and medium terms post-AVR. We aimed to determine the prognostic value of the presence of a restrictive left-ventricular (LV) diastolic filling pattern (LVDFP) and dilated left atrium (LA) in patients with AS and LV systolic dysfunction (LVEF < 40%) who underwent AVR, and to define the independent predictors for immediate and long-term prognosis and their value for preoperative risk estimation. Materials and Methods: The study was prospective and included 197 patients with surgical AS and LVEF <40% who underwent AVR. Preoperative echocardiographic examinations were repeated at day 10, at 1, 3 and 6 months, and at 1 and 2 years after surgery, with evaluation of LVEF, diastolic function and LA dimension index (mm/m2). Depending on LV systolic performance, patients were classified as Group A (LVEF: 30–40%) or Group B (LVEF < 30%). Results: The main echographic independent parameters for early and late postoperative death were: restrictive LVDFP, significant pulmonary hypertension, LV end-systolic diameter (LVESD) >55 mm and the presence of second-degree mitral regurgitation. Restrictive LVDFP and LA dimension >30 mm/m2 were independent predictors for fatal outcome (p = 0.0017). Conclusions: Assessment of diastolic function and LA dimension are reliable parameters in predicting fatal outcome and hospitalization for heart failure, having an independent and incremental prognostic value in patients with surgical AS. Complete evaluation of LVDFP with all the echographic measurements (including TDI) should routinely be part of the preoperative assessment of patients with LV systolic dysfunction undergoing AVR.

Apical Ballooning Syndrome: A Cardiac Syndrome Mimicking Acute Myocardial Infarction

Introduction: Apical ballooning syndrome, Takotsubo cardiomyopathy, or broken heart syndrome, is a rare but currently well recognized clinical entity. It occurs after severe emotional or physical stress, most often in postmenopausal women, and mimics the symptoms and signs of acute coronary syndrome, in the absence of significant coronary injury. This cardiomyopathy is rapidly and completely reversible. The exact pathophysiological mechanism of the condition remains debated; several hypotheses have been put forward, the most credible of which seems to be a sudden hyperadrenergic reaction related to stress. Objective: To report the case of a patient with clinical features of possible myocardial infarction but diagnosed as Takotsubo cardiomyopathy. Case Report: The patient was a 64-year-old woman with no cardiovascular risk factors other than age and menopause, and no particular pathological history. She was admitted on Day 3 with infarct-like chest pain, which appeared following an episode of emotional stress, associated with NYHA stage III dyspnea. On admission, the patient was pain free. The clinical examination found a conscious patient, hemodynamically and respiratory stable, apyretic. The cardiovascular examination was unremarkable. The ECG was in sinus rhythm, showing a QS aspect in the anterosepto-apical area associated with negative T waves in the inferolateral area. The biological workup showed an inflammatory syndrome, with positive troponin at 650ng/l. The thoracic echocardiography showed an aspect of hypokinetic cardiopathy at the dilated stage with severe LV dysfunction (LVEF at 38%), a thin and flexible mitral valve with restriction of the small mitral valve with moderate mitral insufficiency (SOR at 20 cm2 and RV at 19 ml), a dilated left atrium. Coronary angiography showed angiographically healthy coronary arteries, and an MRI was performed, confirming the diagnosis of Takutsbo cardiomyopathy. Discussion and Conclusion: Takotsubo cardiomyopathy is an increasingly recognized clinical entity, characterized by apical left ventricular dysfunction with chest pain, electrocardiographic changes, minimal biomarker changes, and no coronary lesions. In most cases, an episode of emotional or physical stress precedes the event. Its pathophysiological mechanism remains unknown, but high circulating catecholamines seem to be the triggering factor and the most plausible explanation for this primary acquired cardiomyopathy. It is important to be aware of this diagnosis in patients presenting with ACS because its evolution is most often spontaneously favorable.

Reablation in Atrial Fibrillation Recurrence and Pulmonary Vein Reconnection: Cryoballoon versus Radiofrequency as Index Ablation Procedures.

Pulmonary vein (PV) isolation is a well-established rhythm control therapy in atrial fibrillation (AF). Currently, there is no consensus on which ablation technique to use for the first procedure, cryoballoon (CB) or radiofrequency (RF). A retrospective cohort study was conducted on 1055 patients who underwent a first ablation, to assess both techniques based on the need for reablation. Patients with CB (n = 557) and RF (n = 498) ablations were clinically characterized and the need for reablation during a 30-month follow-up was used as the primary endpoint. Independent variables were analyzed to identify potential predictors. The need for reablation was significantly lower in the CB group than in the RF group (hazard ratio = 0.45 and 95% confident interval = 0.32–0.61; p < 0.001); in both paroxysmal and persistent AF, using a full-adjusted regression Cox model by age, sex, smoking, hypertension, diabetes mellitus, dyslipidemia, severe obstructive sleep apnea, dilated left atrium, persistent AF and early recurrence. RF ablation, dilated left atrium, persistent AF and early recurrence were identified as independent predictors of reablation. In addition, the CB-redo subgroup had a lower PV reconnection than the RF-redo subgroup. In conclusion, CB ablation suggests a reduction in the need for reablation and lower PV reconnection during the follow-up than RF ablation.

Left atrial volume, function and B-lines at rest and during vasodilator stress echocardiography

Abstract Background Left atrial volume index (LAVi), left atrial reservoir function assessed with global peak amplitude longitudinal strain (PALS), and B-lines at lung ultrasound are supplementary markers of left ventricular filling pressures. Aim To assess the relationship between LAVi, PALS and B-lines at rest and peak vasodilator stress. Methods A comprehensive dipyridamole stress echo was completed in 266 patients (187 male, 71%, age 65±10 years) with chronic coronary syndromes. LAVi was measured with the biplane disk summation method. PALS was measured from a single vendor with 2-dimensional speckle tracking echocardiography and expressed in % values as the mean of the 12 atrial segments from 4- and 2-chamber values. B-lines were assessed with the simplified 4-site scan in the third intercostal space, with global score from 0 to 40, and considered significant with global score ≥2 units. Results During dipyridamole, LAVi decreased (rest= 26±14 ml/m2 vs stress= 24±12 ml/m2, p&amp;lt;0.001), PALS increased (rest= 33±8 vs stress= 38±10%, p&amp;lt;0.001), and B-lines were more frequent (rest= 0.4, median interquartile range 0–30, vs stress= 0.7, median interquartile range 0–30, units, p&amp;lt;0.001). There was a significant, linear, inverse correlation between LAVi and PALS both at rest (r=−0.301, p&amp;lt;0.001) and at peak stress (r=−0.279, p&amp;lt;0.001, see figure). At group analysis, peak B-lines were directly correlated with peak LAVi (r=0.151, p=0.017) and inversely correlated with peak PALS (r=−0.234, p&amp;lt;0.001). At individual patient analysis, 4/93 patients (4.3%) showed stress B-lines (black dots in figure) with normal LAVi (&amp;lt;34 ml/m2) and preserved PALS (&amp;gt;42%). Conclusion Vasodilator stress echocardiography with combined assessment of left atrial volume, function and pulmonary congestion is feasible with high success rate in patients with chronic coronary syndromes. Pulmonary congestion is more frequent with dilated left atrium with reduced atrial contractile reserve, but it may occur in a minority of patients with normal LAVi and normal PALS. Funding Acknowledgement Type of funding sources: None.